<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Alzheimer&#39;s Disease - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Alzheimer&#39;s Disease</span>
        </nav>

        <header class="page-header">
            <h1>Alzheimer&#39;s Disease</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0004975" target="_blank">
                        MONDO:0004975
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Dementia</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Neurodegenerative Disease</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                Alzheimer&#39;s Disease is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and behavioral changes. It is the most common cause of dementia, involving the accumulation of amyloid-beta plaques and neurofibrillary tangles in the brain, leading to neuronal death and brain atrophy.

            </p>
            
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">nervous system disorder</span>
                    
                    <span class="tag tag-classification">neurodegenerative disease</span>
                    
                </div>
            </div>
            
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Mechanistic Nosology</div>
                <div class="tag-list">
                    
                    <span class="tag tag-mechanistic">tauopathy</span>
                    
                </div>
            </div>
            
            
            
            
            
        </div>
        

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Amyloid-Beta Plaque Formation</div>
                
                <div class="item-desc">Extracellular accumulation of amyloid-beta (AŒ≤) peptides into senile plaques. AŒ≤ is produced through sequential cleavage of amyloid precursor protein (APP) by Œ≤-secretase and Œ≥-secretase. Soluble oligomeric forms of AŒ≤ are toxic to synapses and interfere with synaptic plasticity and memory formation.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000540" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        microglial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000129" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        amyloid precursor protein catabolic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042987" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚ö† ABNORMAL
    </span>
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21456963" target="_blank">PMID:21456963</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Alzheimer&#39;s disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the Œ≤-amyloid peptide (AŒ≤) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau."</div>
                
                
                <div class="evidence-explanation">Confirms that AŒ≤ accumulation in the brain is a hallmark characteristic of Alzheimer&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21456963" target="_blank">PMID:21456963</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"physiologic generation of the neurotoxic AŒ≤ peptide from sequential amyloid precursor protein (APP) proteolysis is the crucial step in the development of AD. APP is a single-pass transmembrane protein expressed at high levels in the brain and metabolized in a rapid and highly complex fashion by..."</div>
                
                
                <div class="evidence-explanation">Describes the sequential proteolytic processing of APP by secretases to generate AŒ≤ peptides.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neurofibrillary Tangle Formation</div>
                
                <div class="item-desc">Intracellular accumulation of hyperphosphorylated tau protein forming neurofibrillary tangles (NFTs). Tau normally stabilizes microtubules, but abnormal hyperphosphorylation by various kinases reduces its affinity for microtubules, leading to accumulation of free tau that aggregates into paired helical filaments and NFTs. This causes mitochondrial dysfunction, impairs synaptic plasticity, and triggers neuroinflammation.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000540" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37264120" target="_blank">PMID:37264120</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Tau protein hyperphosphorylation was the first pathological post-translational modification of tau protein described in Alzheimer&#39;s disease (AD), highlighting the role of PKs in neurodegeneration."</div>
                
                
                <div class="evidence-explanation">Confirms that tau hyperphosphorylation is a key pathological feature of Alzheimer&#39;s disease and involves protein kinases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21456963" target="_blank">PMID:21456963</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Alzheimer&#39;s disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the Œ≤-amyloid peptide (AŒ≤) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau."</div>
                
                
                <div class="evidence-explanation">Documents that hyperphosphorylated tau is a characteristic neuropathological hallmark of Alzheimer&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Synaptic Dysfunction</div>
                
                <div class="item-desc">Oligomeric forms of AŒ≤ and tau are toxic to synapses, interfering with molecular pathways required for synaptic plasticity and memory. This synaptic dysfunction precedes neuronal death and correlates with cognitive impairment severity.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000540" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28059794" target="_blank">PMID:28059794</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The loss of synapses in the affected brain regions correlates best with cognitive impairment in AD patients and has been considered as the early mechanism that precedes neuronal loss."</div>
                
                
                <div class="evidence-explanation">Confirms that synaptic loss correlates with cognitive impairment and precedes neuronal death in Alzheimer&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28059794" target="_blank">PMID:28059794</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Increased production of reactive oxygen species (ROS) associated with age- and disease-dependent loss of mitochondrial function, altered metal homeostasis, and reduced antioxidant defense directly affect synaptic activity and neurotransmission in neurons leading to cognitive dysfunction."</div>
                
                
                <div class="evidence-explanation">Describes how oxidative stress affects synaptic activity and neurotransmission, contributing to cognitive dysfunction.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neuroinflammation</div>
                
                <div class="item-desc">Chronic activation of microglia and astrocytes in response to AŒ≤ plaques and tau tangles. While initially attempting to clear pathological proteins, sustained inflammation produces pro-inflammatory cytokines and reactive oxygen species that damage neurons and exacerbate neurodegeneration.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        microglial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000129" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32048973" target="_blank">PMID:32048973</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"An emerging concept is that microglia, the innate immune cells of the brain, are major players in AD pathogenesis. Microglia are longlived tissue-resident professional phagocytes that survey and rapidly respond to changes in their microenvironment. Subpopulations of microglia cluster around AŒ≤..."</div>
                
                
                <div class="evidence-explanation">Describes how microglia respond to AŒ≤ plaques and play a major role in AD pathogenesis through neuroinflammation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32048973" target="_blank">PMID:32048973</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A plethora of molecules and pathways associated with microglia function and dysfunction has been identified as important players in mediating neurodegeneration."</div>
                
                
                <div class="evidence-explanation">Confirms the role of microglial dysfunction in mediating neurodegeneration in Alzheimer&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neuronal Death</div>
                
                <div class="item-desc">Progressive loss of neurons, particularly in the hippocampus and cortex, leading to brain atrophy. Neuronal death results from accumulated damage from AŒ≤ toxicity, tau pathology, mitochondrial dysfunction, oxidative stress, and neuroinflammation.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000540" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28059794" target="_blank">PMID:28059794</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Abnormal cellular metabolism in turn could affect the production and accumulation of amyloid-Œ≤ (AŒ≤) and hyperphosphorylated Tau protein, which independently could exacerbate mitochondrial dysfunction and ROS production, thereby contributing to a vicious cycle."</div>
                
                
                <div class="evidence-explanation">Describes the vicious cycle of AŒ≤, tau, and oxidative stress that leads to neuronal damage and death.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28059794" target="_blank">PMID:28059794</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Alzheimer&#39;s disease (AD) is a devastating neurodegenerative disorder without a cure. Most AD cases are sporadic where age represents the greatest risk factor."</div>
                
                
                <div class="evidence-explanation">Confirms Alzheimer&#39;s as a neurodegenerative disorder characterized by progressive neuronal loss.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="graph-warning">
                <strong>Referential integrity issues (2):</strong>
                <ul>
                    
                    <li>Target &#39;Cognitive Decline&#39; (from &#39;Synaptic Dysfunction&#39;) not found in named elements</li>
                    
                    <li>Target &#39;Brain Atrophy&#39; (from &#39;Neuronal Death&#39;) not found in named elements</li>
                    
                    
                </ul>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph TD
    Neuroinflammation[&#34;Neuroinflammation&#34;]
    Amyloid_Beta_Plaque_Formation[&#34;Amyloid-Beta Plaque Formation&#34;]
    Memory_Impairment[&#34;Memory Impairment&#34;]
    Neurofibrillary_Tangle_Formation[&#34;Neurofibrillary Tangle Formation&#34;]
    Neuronal_Death[&#34;Neuronal Death&#34;]
    Brain_Atrophy[&#34;Brain Atrophy&#34;]
    Synaptic_Dysfunction[&#34;Synaptic Dysfunction&#34;]
    Cognitive_Decline[&#34;Cognitive Decline&#34;]
    Dementia[&#34;Dementia&#34;]

    Amyloid_Beta_Plaque_Formation --&gt; Synaptic_Dysfunction
    Amyloid_Beta_Plaque_Formation --&gt; Neuroinflammation
    Neurofibrillary_Tangle_Formation --&gt; Synaptic_Dysfunction
    Neurofibrillary_Tangle_Formation --&gt; Neuronal_Death
    Synaptic_Dysfunction --&gt; Memory_Impairment
    Synaptic_Dysfunction -.-&gt; Cognitive_Decline
    Neuroinflammation --&gt; Neuronal_Death
    Neuronal_Death -.-&gt; Brain_Atrophy
    Neuronal_Death --&gt; Dementia

    style Neuroinflammation fill:#dbeafe
    style Amyloid_Beta_Plaque_Formation fill:#dbeafe
    style Memory_Impairment fill:#fef3c7
    style Neurofibrillary_Tangle_Formation fill:#dbeafe
    style Neuronal_Death fill:#dbeafe
    style Brain_Atrophy fill:#fee2e2,stroke:#dc2626,stroke-dasharray: 5 5
    style Synaptic_Dysfunction fill:#dbeafe
    style Cognitive_Decline fill:#fee2e2,stroke:#dc2626,stroke-dasharray: 5 5
    style Dementia fill:#fef3c7</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Memory Impairment
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002354" target="_blank">
                            HP:0002354
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Memory impairment is among the first and most prominent symptoms, affecting working memory and long-term declarative memory early in the disease course.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24459411" target="_blank">PMID:24459411</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Loss of memory is among the first symptoms reported by patients suffering from Alzheimer&#39;s disease (AD) and by their caretakers. Working memory and long-term declarative memory are affected early during the course of the disease."</div>
                
                
                <div class="evidence-explanation">This reference confirms that memory loss, including both working memory and long-term declarative memory, is an early and characteristic symptom of Alzheimer&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31724515" target="_blank">PMID:31724515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Memory impairment has been considered as one of the earliest clinical hallmarks of Alzheimer&#39;s disease."</div>
                
                
                <div class="evidence-explanation">This confirms memory impairment as a defining early clinical feature of Alzheimer&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Cognitive Impairment
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0100543" target="_blank">
                            HP:0100543
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Progressive decline in cognitive domains beyond memory, including executive function, language, and visuospatial abilities.</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Dementia
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000726" target="_blank">
                            HP:0000726
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Progressive cognitive decline sufficient to interfere with daily functioning and independence, representing the advanced stage of Alzheimer&#39;s disease.</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    APP
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Mutations cause early-onset autosomal dominant Alzheimer disease)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28002825" target="_blank">PMID:28002825</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years."</div>
                
                
                <div class="evidence-explanation">This confirms that APP mutations cause autosomal dominant early-onset Alzheimer&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PSEN1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Most common cause of early-onset autosomal dominant Alzheimer disease)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28002825" target="_blank">PMID:28002825</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years."</div>
                
                
                <div class="evidence-explanation">This confirms that PSEN1 mutations cause autosomal dominant early-onset Alzheimer&#39;s disease with high penetrance.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PSEN2
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Rare cause of early-onset autosomal dominant Alzheimer disease)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28002825" target="_blank">PMID:28002825</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years."</div>
                
                
                <div class="evidence-explanation">This confirms that PSEN2 mutations can cause autosomal dominant early-onset Alzheimer&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    APOE
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(APOE Œµ4 allele is the strongest genetic risk factor for late-onset Alzheimer disease)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28002825" target="_blank">PMID:28002825</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Among them, the APOE Œµ4 allele is a rare example of a common allele with a large effect size, the ORs ranging from 4 to 11-14 for heterozygous and homozygous carriers, respectively."</div>
                
                
                <div class="evidence-explanation">This demonstrates the substantial genetic risk conferred by the APOE Œµ4 allele for Alzheimer&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24459411" target="_blank">PMID:24459411</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The investigation of AD memory loss helps to identify the involved neural structures, such as the default mode network, the influence of epigenetic and genetic factors, such as ApoE4 status, and evolutionary aspects of human cognition."</div>
                
                
                <div class="evidence-explanation">This reference highlights ApoE4 as an important genetic factor influencing Alzheimer&#39;s disease pathology and memory loss.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Cholinesterase Inhibitors
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Medications such as donepezil, rivastigmine, and galantamine that inhibit acetylcholinesterase to increase acetylcholine availability in the brain, providing modest symptomatic improvement in cognitive function.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    NMDA Receptor Antagonist
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Memantine blocks NMDA receptors to reduce glutamate excitotoxicity and may provide modest cognitive and functional benefits, particularly in moderate to severe Alzheimer&#39;s disease.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Cognitive Stimulation and Rehabilitation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Non-pharmacological interventions including cognitive training, reality orientation, and memory rehabilitation to maintain cognitive function and quality of life.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Alzheimer&#39;s Disease
description: &gt;
  Alzheimer&#39;s Disease is a progressive neurodegenerative disorder characterized by
  cognitive decline, memory loss, and behavioral changes. It is the most common cause
  of dementia, involving the accumulation of amyloid-beta plaques and neurofibrillary
  tangles in the brain, leading to neuronal death and brain atrophy.
category: Complex
disease_term:
  preferred_term: Alzheimer disease
  term:
    id: MONDO:0004975
    label: Alzheimer disease
parents:
- Dementia
- Neurodegenerative Disease
pathophysiology:
- name: Amyloid-Beta Plaque Formation
  description: &gt;
    Extracellular accumulation of amyloid-beta (AŒ≤) peptides into senile plaques.
    AŒ≤ is produced through sequential cleavage of amyloid precursor protein (APP)
    by Œ≤-secretase and Œ≥-secretase. Soluble oligomeric forms of AŒ≤ are toxic to
    synapses and interfere with synaptic plasticity and memory formation.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  - preferred_term: microglial cell
    term:
      id: CL:0000129
      label: microglial cell
  biological_processes:
  - preferred_term: amyloid precursor protein catabolic process
    term:
      id: GO:0042987
      label: amyloid precursor protein catabolic process
    modifier: ABNORMAL
  downstream:
  - target: Synaptic Dysfunction
  - target: Neuroinflammation
  evidence:
  - reference: PMID:21456963
    supports: SUPPORT
    snippet: &#34;Alzheimer&#39;s disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the Œ≤-amyloid peptide (AŒ≤) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau.&#34;
    explanation: Confirms that AŒ≤ accumulation in the brain is a hallmark characteristic of Alzheimer&#39;s disease.
  - reference: PMID:21456963
    supports: SUPPORT
    snippet: &#34;physiologic generation of the neurotoxic AŒ≤ peptide from sequential amyloid precursor protein (APP) proteolysis is the crucial step in the development of AD. APP is a single-pass transmembrane protein expressed at high levels in the brain and metabolized in a rapid and highly complex fashion by a series of sequential proteases, including the intramembranous Œ≥-secretase complex&#34;
    explanation: Describes the sequential proteolytic processing of APP by secretases to generate AŒ≤ peptides.
- name: Neurofibrillary Tangle Formation
  description: &gt;
    Intracellular accumulation of hyperphosphorylated tau protein forming neurofibrillary
    tangles (NFTs). Tau normally stabilizes microtubules, but abnormal hyperphosphorylation
    by various kinases reduces its affinity for microtubules, leading to accumulation
    of free tau that aggregates into paired helical filaments and NFTs. This causes
    mitochondrial dysfunction, impairs synaptic plasticity, and triggers neuroinflammation.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  downstream:
  - target: Synaptic Dysfunction
  - target: Neuronal Death
  evidence:
  - reference: PMID:37264120
    supports: SUPPORT
    snippet: &#34;Tau protein hyperphosphorylation was the first pathological post-translational modification of tau protein described in Alzheimer&#39;s disease (AD), highlighting the role of PKs in neurodegeneration.&#34;
    explanation: Confirms that tau hyperphosphorylation is a key pathological feature of Alzheimer&#39;s disease and involves protein kinases.
  - reference: PMID:21456963
    supports: SUPPORT
    snippet: &#34;Alzheimer&#39;s disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the Œ≤-amyloid peptide (AŒ≤) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau.&#34;
    explanation: Documents that hyperphosphorylated tau is a characteristic neuropathological hallmark of Alzheimer&#39;s disease.
- name: Synaptic Dysfunction
  description: &gt;
    Oligomeric forms of AŒ≤ and tau are toxic to synapses, interfering with molecular
    pathways required for synaptic plasticity and memory. This synaptic dysfunction
    precedes neuronal death and correlates with cognitive impairment severity.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  downstream:
  - target: Memory Impairment
  - target: Cognitive Decline
  evidence:
  - reference: PMID:28059794
    supports: SUPPORT
    snippet: &#34;The loss of synapses in the affected brain regions correlates best with cognitive impairment in AD patients and has been considered as the early mechanism that precedes neuronal loss.&#34;
    explanation: Confirms that synaptic loss correlates with cognitive impairment and precedes neuronal death in Alzheimer&#39;s disease.
  - reference: PMID:28059794
    supports: SUPPORT
    snippet: &#34;Increased production of reactive oxygen species (ROS) associated with age- and disease-dependent loss of mitochondrial function, altered metal homeostasis, and reduced antioxidant defense directly affect synaptic activity and neurotransmission in neurons leading to cognitive dysfunction.&#34;
    explanation: Describes how oxidative stress affects synaptic activity and neurotransmission, contributing to cognitive dysfunction.
- name: Neuroinflammation
  description: &gt;
    Chronic activation of microglia and astrocytes in response to AŒ≤ plaques and
    tau tangles. While initially attempting to clear pathological proteins, sustained
    inflammation produces pro-inflammatory cytokines and reactive oxygen species
    that damage neurons and exacerbate neurodegeneration.
  cell_types:
  - preferred_term: microglial cell
    term:
      id: CL:0000129
      label: microglial cell
  downstream:
  - target: Neuronal Death
  evidence:
  - reference: PMID:32048973
    supports: SUPPORT
    snippet: &#34;An emerging concept is that microglia, the innate immune cells of the brain, are major players in AD pathogenesis. Microglia are longlived tissue-resident professional phagocytes that survey and rapidly respond to changes in their microenvironment. Subpopulations of microglia cluster around AŒ≤ plaques and adopt a transcriptomic signature specifically linked to neurodegeneration.&#34;
    explanation: Describes how microglia respond to AŒ≤ plaques and play a major role in AD pathogenesis through neuroinflammation.
  - reference: PMID:32048973
    supports: SUPPORT
    snippet: &#34;A plethora of molecules and pathways associated with microglia function and dysfunction has been identified as important players in mediating neurodegeneration.&#34;
    explanation: Confirms the role of microglial dysfunction in mediating neurodegeneration in Alzheimer&#39;s disease.
- name: Neuronal Death
  description: &gt;
    Progressive loss of neurons, particularly in the hippocampus and cortex, leading
    to brain atrophy. Neuronal death results from accumulated damage from AŒ≤ toxicity,
    tau pathology, mitochondrial dysfunction, oxidative stress, and neuroinflammation.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  downstream:
  - target: Brain Atrophy
  - target: Dementia
  evidence:
  - reference: PMID:28059794
    supports: SUPPORT
    snippet: &#34;Abnormal cellular metabolism in turn could affect the production and accumulation of amyloid-Œ≤ (AŒ≤) and hyperphosphorylated Tau protein, which independently could exacerbate mitochondrial dysfunction and ROS production, thereby contributing to a vicious cycle.&#34;
    explanation: Describes the vicious cycle of AŒ≤, tau, and oxidative stress that leads to neuronal damage and death.
  - reference: PMID:28059794
    supports: SUPPORT
    snippet: &#34;Alzheimer&#39;s disease (AD) is a devastating neurodegenerative disorder without a cure. Most AD cases are sporadic where age represents the greatest risk factor.&#34;
    explanation: Confirms Alzheimer&#39;s as a neurodegenerative disorder characterized by progressive neuronal loss.
phenotypes:
- category: Neurological
  name: Memory Impairment
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Memory impairment is among the first and most prominent symptoms, affecting working memory and long-term declarative memory early in the disease course.
  evidence:
  - reference: PMID:24459411
    supports: SUPPORT
    snippet: Loss of memory is among the first symptoms reported by patients suffering from Alzheimer&#39;s disease (AD) and by their caretakers. Working memory and long-term declarative memory are affected early during the course of the disease.
    explanation: This reference confirms that memory loss, including both working memory and long-term declarative memory, is an early and characteristic symptom of Alzheimer&#39;s disease.
  - reference: PMID:31724515
    supports: SUPPORT
    snippet: Memory impairment has been considered as one of the earliest clinical hallmarks of Alzheimer&#39;s disease.
    explanation: This confirms memory impairment as a defining early clinical feature of Alzheimer&#39;s disease.
  phenotype_term:
    preferred_term: Memory impairment
    term:
      id: HP:0002354
      label: Memory impairment
- category: Neurological
  name: Cognitive Impairment
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Progressive decline in cognitive domains beyond memory, including executive function, language, and visuospatial abilities.
  phenotype_term:
    preferred_term: Cognitive impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
- category: Neurological
  name: Dementia
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Progressive cognitive decline sufficient to interfere with daily functioning and independence, representing the advanced stage of Alzheimer&#39;s disease.
  phenotype_term:
    preferred_term: Dementia
    term:
      id: HP:0000726
      label: Dementia
genetic:
- name: APP
  association: Mutations cause early-onset autosomal dominant Alzheimer disease
  notes: Amyloid precursor protein gene; mutations increase production of aggregation-prone AŒ≤ peptides, triggering pathological cascade. Accounts for 10-15% of autosomal dominant early-onset AD cases.
  evidence:
  - reference: PMID:28002825
    supports: SUPPORT
    snippet: Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years.
    explanation: This confirms that APP mutations cause autosomal dominant early-onset Alzheimer&#39;s disease.
- name: PSEN1
  association: Most common cause of early-onset autosomal dominant Alzheimer disease
  notes: Presenilin 1 gene; encodes component of Œ≥-secretase complex. Mutations alter APP processing to increase AŒ≤42/AŒ≤40 ratio. Over 300 pathogenic mutations identified; accounts for 30-70% of autosomal dominant early-onset AD cases.
  evidence:
  - reference: PMID:28002825
    supports: SUPPORT
    snippet: Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years.
    explanation: This confirms that PSEN1 mutations cause autosomal dominant early-onset Alzheimer&#39;s disease with high penetrance.
- name: PSEN2
  association: Rare cause of early-onset autosomal dominant Alzheimer disease
  notes: Presenilin 2 gene; encodes component of Œ≥-secretase complex. Mutations have similar effects to PSEN1 but account for less than 5% of autosomal dominant early-onset AD cases.
  evidence:
  - reference: PMID:28002825
    supports: SUPPORT
    snippet: Extremely rare variants in the APP, PSEN1, or PSEN2 genes, or duplications of the APP gene cause autosomal dominant forms, generally with complete penetrance by the age of 65 years.
    explanation: This confirms that PSEN2 mutations can cause autosomal dominant early-onset Alzheimer&#39;s disease.
- name: APOE
  association: APOE Œµ4 allele is the strongest genetic risk factor for late-onset Alzheimer disease
  notes: Apolipoprotein E gene; APOE Œµ4 allele dramatically increases risk for late-onset AD. Heterozygous carriers have OR of 4, homozygous carriers have OR of 11-14. The Œµ4 allele affects AŒ≤ clearance, aggregation, and toxicity.
  evidence:
  - reference: PMID:28002825
    supports: SUPPORT
    snippet: Among them, the APOE Œµ4 allele is a rare example of a common allele with a large effect size, the ORs ranging from 4 to 11-14 for heterozygous and homozygous carriers, respectively.
    explanation: This demonstrates the substantial genetic risk conferred by the APOE Œµ4 allele for Alzheimer&#39;s disease.
  - reference: PMID:24459411
    supports: SUPPORT
    snippet: The investigation of AD memory loss helps to identify the involved neural structures, such as the default mode network, the influence of epigenetic and genetic factors, such as ApoE4 status, and evolutionary aspects of human cognition.
    explanation: This reference highlights ApoE4 as an important genetic factor influencing Alzheimer&#39;s disease pathology and memory loss.
treatments:
- name: Cholinesterase Inhibitors
  description: Medications such as donepezil, rivastigmine, and galantamine that inhibit acetylcholinesterase to increase acetylcholine availability in the brain, providing modest symptomatic improvement in cognitive function.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: NMDA Receptor Antagonist
  description: Memantine blocks NMDA receptors to reduce glutamate excitotoxicity and may provide modest cognitive and functional benefits, particularly in moderate to severe Alzheimer&#39;s disease.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Cognitive Stimulation and Rehabilitation
  description: Non-pharmacological interventions including cognitive training, reality orientation, and memory rehabilitation to maintain cognitive function and quality of life.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
classifications:
  harrisons_chapter:
    - classification_value: nervous system disorder
    - classification_value: neurodegenerative disease
  mechanistic_category:
    - classification_value: tauopathy
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Alzheimers_Disease.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>